BioCentury
ARTICLE | Clinical News

Androxal enclomiphene regulatory update

February 23, 2015 8:00 AM UTC

Repros submitted an NDA to FDA for Androxal enclomiphene to treat secondary hypogonadism in overweight men. The company plans to submit a regulatory application in the EU for the trans-isomer of clomi...